The ISSCR Membership  by unknown
Cell Stem Cell
ISSCR: Annual Report
The ISSCR MembershipThe field of stem cell research continued its rapid growth over the
past year, reflected in a dramatic increase in the ISSCRmember-
ship. With the increasing global nature of stem cell research and
the proliferation of worldwide collaborations, the ISSCR has
become a leading voice for the stem cell community. Over the
past 7 years, the ISSCR has proven vital to providing a unified
outlet for the exchange of global stem cell information through
communications and educational initiatives.
‘‘The ISSCR has rapidly becomeknown as not
only the premier proponent of excellence in
stem cell science worldwide, but also a
trusted voice in the ethical and regulatory
debates on stem cells and their clinical appli-
cations.’’
—Janet Rossant, PhD, Senior Scientist and
Chief of Research, The Hospital for Sick Chil-
dren, and Professor, University of Toronto,
Toronto, ON, Canada
A Year of International Growth
The ISSCR continued to grow under a strong international lead-
ership elected by its members. The ISSCR Board of Directors
consists of 21 members and includes the officer positions of
president, president-elect, vice president, clerk, treasurer, and
past president. Elections take place at the beginning of each
calendar year, with the term of appointment starting following
the annual meeting.
This year, the ISSCRmembership increased by 30%, bringing
the total to 3399. The member renewal rate continued the
upward trend seen in previous years. An influx of 1466 new
members joined the society, bringing fresh perspectives and
expertise. We are encouraged by the number of youngmembers
who continue to join the field and participate in the ISSCR, with
early career scientists (associate members) representing 42% of
the membership.
The ISSCR’s dedication to its mission of promoting and
fostering the exchange of stem cell information worldwide has
proven key to the development of the society, both in size and
also in global representation (Figure 1). The society’s member-
ship now spans 56 countries, an increase from 49 in 2008,
drawing in new countries from Europe, Asia, Africa, and South
America. The European location of the July 2009 Annual Meeting
in Barcelona, Spain—the ISSCR’s first meeting in Europe—
helped realize a 13% increase in European members, who now
represent 29% of the society.
Expanding Engagement and Reach
Embracing new communications methods is imperative as the
ISSCR works to reach members around the globe. In addition
to the web site and e-mail, the ISSCR is now using social
networking forums to both engage and communicate with our
members. In addition to a presence on Facebook, the societynow has more than 750 members in its LinkedIn group and
used Twitter to broadcast session highlights from the 2009
Annual Meeting in Barcelona, giving both attendees and nonat-
tendees a glimpse of the presentations and activities happening
at the conference.
Membership Application
The stem cell research field is developing quickly to include an
increasing component of translational research and to interface
with new clinical, technology-driven, and geographical constitu-
encies. These changes, along with the significant influx of new
members, have brought with them a review of membership
application procedures. In the past year, the Membership
Committee included an addition to the membership application
that asks applicants to confirm their willingness to abide by the
professional standards articulated in the ISSCR Guidelines for
the Conduct of Human Embryonic Stem Cell Research and
Guidelines for the Clinical Translation of StemCells. Membership
is offered on an individual basis only, and applicants without
endorsement from an existing active ISSCR member are now
asked about affiliations they may have with a commercial entity
involved in stem cell or regenerative medicine.
Mission Statement
The International Society for Stem Cell Research is an inde-
pendent, nonprofit organization established to promote and
foster the exchange and dissemination of information and
ideas relating to stem cells, to encourage the general field
of research involving stem cells, and to promote professional
and public education in all areas of stem cell research and
application.
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Figure 1. ISSCR Membership by Region, as of July 23, 2009
Stem cell professionals from 54 countries comprise the ISSCR’s 3399
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ISSCR Officers, 2008 – 2009 
June 14, 2008 – July 11, 2009 (end of 2008 Annual Meeting – end of 2009 Annual Meeting)
ISSCR Board of Directors, 2008 – 2009
June 14, 2008 – July 11, 2009 (end of 2008 Annual Meeting – end of 2009 Annual Meeting)
Peter W. Andrews, BSc, DPhil, MBA, University of Sheffield 
Claudio Bordignon, MD, Vito-Salute San Raffaele Universitario
Margaret Buckingham, DPhil, Pasteur Institute 
Lawrence S.B. Goldstein, PhD, University of California, San Diego 
Thomas Graf, PhD, Centre for Genomic Regulation
Markus Grompe, MD, Oregon Health & Science University 
Olle Lindvall, MD, PhD, University of Lund 
Daniel Marshak, PhD, PerkinElmer, Inc
Ronald D. McKay, PhD, National Institutes of Health/NINDS
Sally Temple, PhD, New York Neural Stem Cell Institute
Alan Trounson, PhD, California Institute for Regenerative Medicine 
Derek van der Kooy, PhD, University of Toronto
Ian Wilmut, PhD, DSc, University of Edinburgh, Scottish Centre for Regenerative Medicine
Shinya Yamanaka, MD, PhD, Kyoto University
Laurie Zoloth, PhD, Northwestern University Feinberg School of Medicine
Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine, Ontario Cancer Institute – Ex Officio
Paul J. Simmons, PhD, University of Texas Health Science Center at Houston – Ex Officio
Leonard I. Zon, MD, Children’s Hospital Boston – Ex Officio
President
President-Elect
Vice President
Clerk
Treasurer
Past President
Fiona M. Watt, DPhil, Cancer Research UK Cambridge Research Institute
Irving L. Weissman, MD, Stanford University School of Medicine
Elaine Fuchs, PhD, Rockefeller University
Ihor R. Lemischka, PhD, Mount Sinai Medical Center
Sean J. Morrison, PhD, University of Michigan
George Q. Daley, MD, PhD, Children’s Hospital Boston
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